Regulation of 3′,5′-cAMP in preglomerular smooth muscle and endothelial cells from genetically hypertensive rats

Hypertension

Volumn 56, Issue 6, 2010, Pages 1096-1101

  Cheng, Dongmei ^a   Ren, Jin ^a   Gillespie, Delbert G ^a   Mi, Zaichuan ^a   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

3 ,5 cAMP; isoproterenol; phosphodiesterase 4; phosphodiesterase 4B; phosphodiesterase 4B2; spontaneously hypertensive rats; Wistar Kyoto rats

Indexed keywords

CYCLIC AMP; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IVB2; UNCLASSIFIED DRUG; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; PHOSPHODIESTERASE IV INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; GENETICALLY HYPERTENSIVE RAT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; URINARY EXCRETION; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT; ANIMAL; DRUG EFFECT; ENZYMOLOGY; GENETICS; HYPERTENSION; KIDNEY; METABOLISM; VASCULAR ENDOTHELIUM;

1-METHYL-3-ISOBUTYLXANTHINE; 4-(3-BUTOXY-4-METHOXYBENZYL)-2-IMIDAZOLIDINONE; ADRENERGIC BETA-AGONISTS; ANIMALS; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; ENDOTHELIUM, VASCULAR; HYPERTENSION; ISOPROTERENOL; KIDNEY; MALE; MUSCLE, SMOOTH, VASCULAR; PHOSPHODIESTERASE 4 INHIBITORS; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 78650415422     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.160176     Document Type: Article

References (20)

1. Heuze-Joubert I, Mennecier P, Simonet S, Laubie M, Verbeuren TJ. Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated perfused rat kidney. Eur J Pharmacol. 1992;220: 161-171.
2. 4 receptors mediate prostaglandin E(2) actions in the microcirculation of rat kidney. Am J Physiol Renal. 2000;279:F755-F764.
3. Sandner P, Kornfeld M, Ruan X, Arendshorst WJ, Kurtz A. Nitric oxide/cAMP interactions in the control of rat renal vascular resistance. Circ Res. 1999;84:186-192.
4. Chatziantoniou C, Ruan X, Arendshorst WJ. Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension. Am J Physiol. 1993;265:F845-F852.
5. s protein interactions in isolated renal resistance arterioles of spontaneously hypertensive rats. Hypertension. 1999;34: 1134-1140.
6. Chatziantoniou C, Ruan X, Arendshorst WJ. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc Natl Acad Sci USA. 1995;92:2924-2928.
7. Jackson EK, Mi Z. Regulation of renovascular adenosine 3',5'-cyclic monophosphate in spontaneously hypertensive rats. Hypertension. 2009; 54:270-277.
8. Beavo JA, Reifsnyder DH. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci. 1990;11:150-155.
9. Dousa TP. Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int. 1999;55:29-62.
10. Jackson EK, Mi Z. Preglomerular microcirculation expresses the cAMP-adenosine pathway. J Pharmacol Exp Ther. 2000;295:23-28.
11. Dubey RK, Gillespie DG, Jackson EK. Cyclic AMP-adenosine pathway induces nitric oxide synthesis in aortic smooth muscle cells. Hypertension. 1998;31:296-302.
12. Goldman SJ, Dickinson ES, Slakey LL. Effect of adenosine on synthesis and release of cyclic AMP by cultured vascular cells from swine. J Cyclic Nucleotide Protein Phosphor Res. 1983;9:69-78.
13. Mokkapatti R, Vyas SJ, Romero GG, Mi Z, Inoue T, Dubey RK, Gillespie DG, Stout AK, Jackson EK. Modulation by angiotensin II of isoproterenol-induced cAMP production in preglomerular microvascular smooth muscle cells from normotensive and genetically hypertensive rats. J Pharmacol Exp Ther. 1998;287:223-231.
14. Frye CA, Patrick CW Jr. Isolation and culture of rat microvascular endothelial cells. In Vitro Cell Dev Biol Anim. 2002;38:208-212.
15. Jackson EK, Ren J, Mi Z. Extracellular 2',3'-cAMP is a source of adenosine. J Biol Chem. 2009;284:33097-33106.
16. Tawar U, Kotlo K, Jain S, Shukla S, Setty S, Danziger RS. Renal phosphodiesterase 4B is activated in the Dahl salt-sensitive rat. Hypertension. 2008; 51:762-766.
17. Marte A, Pepicelli O, Cavallero A, Raiteri M, Fedele E. In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats. J Neurosci Res. 2008;86:3338-3347.
18. Omori K, Kotera J. Overview of PDEs and their regulation. Circ Res. 2007;100:309-327.
19. Houslay MD, Baillie GS, Maurice DH. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. Circ Res. 2007;100:950-966.
20. Shahid M, Shen L, Seldin DC, Lu B, Ustyugova IV, Chen X, Zapol WM, Wu MX. Impaired 3',5'-cyclic adenosine monophosphate-mediated signaling in immediate early responsive gene X-1-deficient vascular smooth muscle cells Hypertension. 2010;doi:10.1161/HYPERTENSIONAHA.110.154880.